Antimicrobial Susceptibility Patterns and Characterization of Clinical Isolates of Staphylococcus aureus in Immunocompromised Cancer Patients Undergoing Chemotherapy in Pakistan

References

• Lowy FD. Staphylococcus aureus infection. N Engl J Med 1998; 339: 520–532.
   PubMed Web of Science ®Google Scholar
• Duckworth G. Controlling methicillin-resistant Staphylo-coccus aureus. BMJ 2003; 327: 1177–1178.
   PubMedGoogle Scholar
• Jevons MP. Celbenin-resistant staphylococci. BMJ 1961; I: 124-125.
   Google Scholar
• Boyce JM. Epidemiology and prevention of nosocomial in-fections In the Staphylococci in human disease. New York, 1997: 309–329.
   Google Scholar
• Voss A, Milatovic D, Wallrauch-Schwarz C, Rosdahl VT, Braveny I. Methicillin-resistant Staphylococcus aureus in Eu-rope. Eur J Clin Microbiol Infect Dis 1994; 13: 50–55.
   PubMed Web of Science ®Google Scholar
• Panlilio AL, Culver DH, Gaynes RP et al. Methicillin-resis-tant Staphylococcus aureus in U.S. hospitals, 1975-1991. In-fect Control Hosp Epidemiol 1992; 13: 582–586.
   Google Scholar
• Cheesbrough M. District Laboratory Practice in Tropical Countries. Butterworth and Co.UK. 2000.
   Google Scholar
• CLSI. Performance Standards for Antimicrobial Suscepti-bility Testing: Twelfth Informational Supplement. NCCLS docu-ment M100-512 [ISBN 1-56238-454-6]. 2000: CLSI 940 West Valley Road, Suite 1400, Wayne, PA 19087-1898 USA.
   Google Scholar
• Diekema DJ, Pfaller MA, Schmitz FJ et al. Survey of in-fections due to Staphylococcus species: frequency of occurrence and antimicrobial susceptibility of isolates collected in the United States, Canada, Latin America, Europe, and the Western Pacific region for the SENTRY Antimicrobial Surveillance Program, 1997-1999. Clin Infect Dis 2001; 32 (Suppl. 2): S114-S132.1°
   Google Scholar
• Fluit AC, Wielders CLC, Verhoef J and Schmitz FJ. Epi-demiology and susceptibility of 3,051 Staphylococcus aureus isolates from 25 university hospitals participating in the Euro-pean SENTRY study. J Clin Microbiol 2001; 39: 3727–3732.
   Google Scholar
• Santos S, Mato ISR, de Lancastre H et al. Patterns of multidrug resistance among methicillin-resistant hospital isolates of coagulase-positive and coagulase-negative staphylococci col-lected in the international multicenter study RESIST in 1997 and 1998. Microb Drug Resist 2000; 6 (3): 199-211.
   PubMed Web of Science ®Google Scholar
• Witte W. Antibiotic resistance in gram-positive bacteria: epidemiological aspects. J Antimicrob Chemother 1999; 44: 1–9.
   PubMed Web of Science ®Google Scholar
• Latif S, Anwar MS, Chaudhry NA. The susceptibility pat-tern of nosocomial Methicillin resistant Staphylococcus aureus (MRSA) isolates to vancomycin and other anti- staphylococcal antibiotics. Biomedical 2000; 16: 32–35.
   Google Scholar
• Kholy AE, Baseem H, Hall GS, Proco GW, Longworth DL. Antimicrobial resistance in Cairo, Egypt 1999-2000: a sur-vey of five hospitals. J Antimicrob Chemother 2003; 51: 625–630.
   PubMed Web of Science ®Google Scholar
• Safdar A, Rodriguez GH, Balakrishnan M, Tarrand JJ, Rolston KVI. Changing trends in etiology of bacteremia in pa-tients with cancer. Eur J Clin Microbiol Infect Dis 2006; 8 (25): 522–526.
   Google Scholar
• Weinstein MP, Towns ML, Quartey SM et al. The clinical significance of positive blood culture in the 1990s: a prospective comprehensive evaluation of the microbiology, epidemiology and outcome of bacteremeia and fungemia in adults. Clin Infect Dis 1997; 4: 584–602.
   Google Scholar
• Perwaiz S, Barakzi Q, Farooqi BJ, Khursheed N, Sabir N. Antimicrobial susceptibility pattern of clinical isolates of methi-cillin resistant Staphylococcus aureus. 2007; J Pak Med Assoc 57 (1): 2-4.
   Google Scholar
• Bukhari MH, Iqbal A, Khatoon N et al. A laboratory study of susceptibility of methicillin resistant Staphylococcus aureus (MRSA). Pak J Med 2004; 20 (3): 229-233.
   Google Scholar
• Brites C, Silva N, Marcia SS. Temporal evolution of the prevalence of methicillin-resistant Staphylococcus aureus in a tertiary hospital in Bahia, Brazil. A nine-year evaluation study. Braz J Infect Dis 2006; 10 (4).
   Google Scholar
• Blot SI, Vandewoude KH, Hoste EA, Colardyn FA. Outcome and attributable mortality in critically ill patients with bac-teremia involving methicillin-susceptible and methicillin-resistant Staphylococcus aureus. Arch Int Med 2002; 162: 2229–2235.
   PubMed Web of Science ®Google Scholar
• Boos M, Mayer S, Fischer A et al. In vitro development of resistance to six quinolones in Streptococcus pneumoniae, Streptococcus pyogenes, and Staphylococcus aureus. AAC 2001; 45 (3): 938-942.
   Google Scholar
• Andrew E, Simor MD. Containing methicillin-resistant S. aureus: surveillance, control, and treatment methods. Postgrad Med 2001; 110 (4): 43-48.
   Google Scholar
• Duckworth G. Controlling methicillin-resistant Staphylo-coccus aureus. BMJ 2003; 327: 1177–1178.
   PubMedGoogle Scholar
• Shopsin B, Kreiswirth BN. Molecular epidemiology of me-thicillin-resistant Staphylococcus aureus. Emerg Infect Dis 2001; 7: 323–326.
   PubMed Web of Science ®Google Scholar
• Hafiz S, Hafiz AN, Ali Let al. Methicillin resistant Staphy-lococcus aureus: a multicentre study. J Pak Med Assoc 2002; 52: 312–314.
   Google Scholar
• Qureshi AH, Qamar MA, Hussain M, Ali N, Ijaz A. Preva-lence of methicillin resistant Staphylococcus aureus (MRSA). Pak Armed Forces Med J 2000; 50: 91–93.
   Google Scholar
• Griethuysen AV, Veen AV, Suiting A, Walsh T, Kluyt-mans J. High percentage of methicillin-resistant Staphylococcus aureus isolates with reduced susceptibility to glycopeptides in The Netherlands. J Clin Microbiol 2003; 41: 2487–2491.
   PubMed Web of Science ®Google Scholar
• Hughes WT, Armstrong D, Bodley GP, Bow EJ, Brown AE, Calandra et al. Guidelines for the use of antimicrobial agents in neutropenic patients with cancer. Infectious Diseases Society of America. Clin Infect Dis 2002; 34: 730–51
   PubMed Web of Science ®Google Scholar